Join to View Full Profile
471 forest avenueTeaneck, NJ 07666
Phone+1 201-836-3805
Dr. Zeffren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1980
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1975 - 1978
Saint Louis University School of MedicineClass of 1975
Certifications & Licensure
NJ State Medical License 1984 - 2025
NY State Medical License 1976 - 2025
Publications & Presentations
PubMed
- 23 citationsInterleukin-2 and interferon-alpha-2a outpatient therapy for metastatic renal cell carcinoma.Allan Lipton, Harold A. Harvey, Elise Givant, Kenneth D. Hopper, Joan Lawler
Journal of Immunotherapy With Emphasis on Tumor Immunology. 1993-02-01 - 16 citationsA phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.Robert P. Whitehead, Robert A. Figlin, Marc L. Citron, Julia Pfile, Nancy Moldawer
Journal of Immunotherapy With Emphasis on Tumor Immunology. 1993-02-01 - 91 citationsConcomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.Robert A. Figlin, Arie S. Belldegrun, Nancy Moldawer, Jacob Zeffren, Jean B. deKernion
Journal of Clinical Oncology. 1992-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
